Y-mAbs Therapeutics A/S is a Danish A/S based in Hørsholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2015, the company has 16 employees and reported revenue of 29,3 mio. kr. in its latest annual filing.
In its most recent annual report (2025), Y-mAbs Therapeutics A/S reported a gross profit of 29,3 mio. kr., a decrease of 61% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 38,5 mio. kr., and the EBITDA margin stood at -154.6%.
At the end of 2025, current assets covered short-term debt 0.1 times. Y-mAbs Therapeutics A/S is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.